BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 22370979)

  • 1. [Assessment the efficacy of postoperative radiotherapy in the patients with non-small cell lung cancer. Retrospective study].
    Chmielewska E; Jodkiewicz Z; Karwański M
    Pneumonol Alergol Pol; 2012; 80(2):109-19. PubMed ID: 22370979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative radiotherapy in radically resected non-small cell lung cancer.
    Mayer R; Smolle-Juettner FM; Szolar D; Stuecklschweiger GF; Quehenberger F; Friehs G; Hackl A
    Chest; 1997 Oct; 112(4):954-9. PubMed ID: 9377958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment outcome of locally advanced stage IIIA/B lung cancer].
    Cicenas S; Zaliene A; Atkocius V
    Medicina (Kaunas); 2009; 45(6):452-9. PubMed ID: 19605965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase II study of concurrent carboplatin and paclitaxel and thoracic radiotherapy for completely resected stage II and IIIA non-small cell lung cancer.
    Feigenberg SJ; Hanlon AL; Langer C; Goldberg M; Nicolaou N; Millenson M; Coia LR; Lanciano R; Movsas B
    J Thorac Oncol; 2007 Apr; 2(4):287-92. PubMed ID: 17409799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
    Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
    Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PORTAF - postoperative radiotherapy of non-small cell lung cancer: accelerated versus conventional fractionation - study protocol for a randomized controlled trial.
    Bütof R; Simon M; Löck S; Troost EGC; Appold S; Krause M; Baumann M
    Trials; 2017 Dec; 18(1):608. PubMed ID: 29262836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent cisplatin/etoposide plus 3D-conformal radiotherapy followed by surgery for stage IIB (superior sulcus T3N0)/III non-small cell lung cancer yields a high rate of pathological complete response.
    Pourel N; Santelmo N; Naafa N; Serre A; Hilgers W; Mineur L; Molinari N; Reboul F
    Eur J Cardiothorac Surg; 2008 May; 33(5):829-36. PubMed ID: 18367406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Surgery in non-small cell lung cancer of the superior sulcus: results of a combined preoperative and postoperative irradiation regime].
    Pfannschmidt J; Muley T; Hoffmann H; Dienemann H
    Zentralbl Chir; 2004 Aug; 129(4):270-5. PubMed ID: 15354247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome and prognostic factors of postoperative radiation therapy (PORT) after incomplete resection of non-small cell lung cancer (NSCLC).
    Rieber J; Deeg A; Ullrich E; Foerster R; Bischof M; Warth A; Schnabel PA; Muley T; Kappes J; Heussel CP; Welzel T; Thomas M; Steins M; Dienemann H; Debus J; Hoffmann H; Rieken S
    Lung Cancer; 2016 Jan; 91():41-7. PubMed ID: 26711933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of high-dose thoracic irradiation incorporating beam's eye view display in non-small cell lung cancer: a retrospective multivariate analysis.
    Hazuka MB; Turrisi AT; Lutz ST; Martel MK; Ten Haken RK; Strawderman M; Borema PL; Lichter AS
    Int J Radiat Oncol Biol Phys; 1993 Sep; 27(2):273-84. PubMed ID: 8407401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Patients Unable to Undergo Adjuvant Chemotherapy after Surgery in Stage IIIA/B Non-Small Cell Lung Cancer: Will They Benefit from Mediastinal Radiotherapy?
    Graeter TP; Sebastian B; Bischof M; Kugler G; Fischer JR; Schneider T
    Thorac Cardiovasc Surg; 2016 Sep; 64(6):501-6. PubMed ID: 26322832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of postoperative thoracic radiotherapy on the survival of patients with stage IIIA (N2 disease) non-small-cell lung cancer].
    Chabowski M; Orłowski TM
    Pol Merkur Lekarski; 2004 Oct; 17(100):345-8. PubMed ID: 15690698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Middle fraction radiotherapy for non-small cell lung cancer. Effect of increasing the total focal dose].
    Sotnikov VM; Panshin GA; Solodky VA; Morgunov AA
    Vopr Onkol; 2015; 61(1):102-8. PubMed ID: 26016154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
    Sonett JR; Suntharalingam M; Edelman MJ; Patel AB; Gamliel Z; Doyle A; Hausner P; Krasna M
    Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Outcome of three-dimensional conformal radiotherapy for early stage non-small cell lung cancer patients who met or not inclusion criteria for stereotactic-body radiation therapy].
    Kołodziejczyk M; Kępka L; Tyc-Szczepaniak D; Wierzchowski M
    Pneumonol Alergol Pol; 2011; 79(5):326-36. PubMed ID: 21861256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The treatment of stage III nonsmall cell lung cancer using high dose conformal radiotherapy.
    Sibley GS; Mundt AJ; Shapiro C; Jacobs R; Chen G; Weichselbaum R; Vijayakumar S
    Int J Radiat Oncol Biol Phys; 1995 Dec; 33(5):1001-7. PubMed ID: 7493826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late complications of high-dose (>/=66 Gy) thoracic conformal radiation therapy in combined modality trials in unresectable stage III non-small cell lung cancer.
    Lee CB; Stinchcombe TE; Moore DT; Morris DE; Hayes DN; Halle J; Rosenman JG; Rivera MP; Socinski MA
    J Thorac Oncol; 2009 Jan; 4(1):74-9. PubMed ID: 19096310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome predictors for 143 patients with superior sulcus tumors treated by multidisciplinary approach at the University of Texas M. D. Anderson Cancer Center.
    Komaki R; Roth JA; Walsh GL; Putnam JB; Vaporciyan A; Lee JS; Fossella FV; Chasen M; Delclos ME; Cox JD
    Int J Radiat Oncol Biol Phys; 2000 Sep; 48(2):347-54. PubMed ID: 10974447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Radiation Dose and Outcomes With Postoperative Radiotherapy for N0-N1 Non-Small Cell Lung Cancer.
    Wang EH; Corso CD; Park HS; Chen AB; Wilson LD; Kim AW; Decker RH; Yu JB
    Am J Clin Oncol; 2018 Feb; 41(2):152-158. PubMed ID: 26523443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radical radiotherapy in stage I non-small cell lung cancer (NSCLC)--Singapore National Cancer Centre experience.
    Low JSh; Koh WY; Yap SP; Fong KW
    Ann Acad Med Singap; 2007 Sep; 36(9):778-83. PubMed ID: 17925989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.